The mRNA Vaccines of the Future: Redesigning Immunization for Today and Beyond

mRNA vaccines are one of the best medical and immunological discoveries of the past few years. While vaccines themselves aren’t exactly new, mRNA technology flips the script on how we think about immunization. mRNA vaccines had been commercialized and distributed thanks to COVID-19, but there’s more to the RNA vaccine than coronavirus. What we’ll be covering in this blog is the science behind mRNA vaccines, what they do, what they have to offer other vaccines, and where we are as an intervention for other infectious diseases and cancer.

What Are mRNA Vaccines?

At their core, an mRNA vaccine is a vaccine in which messenger RNA (mRNA) is used to instruct cells to release an immune-modulating protein. And where traditional vaccines infect or destroy copies of a virus (or protein) they come from, mRNA vaccines don’t even have a virus. Instead, they carry the mRNA to the body, and latch on in cells. They interpret the mRNA code to construct a protein for the virus or pathogen they’re attacking, which, after production, the immune system interprets it as a threat and the engine starts—that’s antibodies, T-cells slaying ‘the evil cells’ later. Furthermore, mRNA is not long-term retained: it’s cleared and destroyed by the immune system once it’s been ‘starved’.

How Do mRNA Vaccines Work?

mRNA Encoding: You can create an mRNA vaccine only if there is a protein in the pathogen that you can design (SARS-CoV-2 spike protein for example). They select this protein because it snags the immune system to attack the bacteria. It’s this protein’s DNA that gets translated into mRNA.

mRNA transmission: LNPs (lipid nanoparticles) coat the mRNA and take it to the cells. Such lipid nanoparticles ensure that mRNA enter cells and stays in cells—mRNA is so porous that it breaks down if not kept in check.

Protein Extraction: Cell ribosome translated mRNA in cell by reading the mRNA and producing the protein. That protein, then, flies to the cell surface.

Immune Response: This extracellular protein is found by the immune system and destroyed with antibodies and T cells, which recognize the protein coding for the mRNA so that, if the patient ever encounters a real infection, they will identify it and destroy it instantly.

Immune Memory: After the immune system has detected the protein, it recalls the virus. Because if the patient has had the virus after, then his body will pick it up, and get on with it faster and better.

Advantages of mRNA Vaccines

mRNA vaccines differ from the other vaccines in these distinct ways:

Time to synthesize: Currently, vaccines use in vitro culture of virus or host live denatured virions, which takes months or years. mRNA vaccines, however, are quicker to programme and produce, for example, the COVID-19 mRNA vaccines, it did not take long between the discovery of the virus and the first vaccine came to the market, And that super-speed slowed the pandemic.

Potential for Infection: As mRNA vaccines are not viruses, the vaccine will not transmit the disease it is against. It’s especially the case for immune patients without live vaccines.

Flexibility: mRNA vaccine platforms are easily adaptable. Not much else to alter for other germs—just replace the mRNA sequence for the viral protein. That’s why mRNA vaccines work not just for seasonal diseases like flu, but new infections like COVID-19 that introduce novel strains.

Powerful Immune Response: Immunity to mRNA vaccines can be antibody (contained virus) or cellular (infected cells). That kind of double reaction is what makes mRNA vaccines so effective against infections.

Scalability and Cost-Effectiveness: It is generally cheaper to scale mRNA vaccines than other vaccines. Since the mRNA is produced in the lab, quicker, maybe cheaper. Nothing to do with having to breed live viruses which is time and money consuming.

The Challenges (Because Nothing’s Perfect)

Storage ‘Drama’: Remember when Pfizer’s vaccine had to be stored at -70°C? That was a logistical nightmare. New formulations are addressing this problem, but it’s still a hurdle.

Long-Term Efficacy and Safety: COVID-19 mRNA vaccines have proven very effective against COVID-19 so far. However, we are still not at a stage to determine long-term efficacy and safety of the vaccines. We don’t know how long the shield lasts and whether boosters will be the norm.

Transmission and Feedback: New tech always gets side-eyes. Some people are still hesitant about mRNA vaccines because they’re not 100% sold on their safety or efficacy.

Using mRNA Vaccines to Shield Humans From COVID-19
But the most virulent use of mRNA vaccines is in the fight against the COVID-19 pandemic. The two most effective COVID-19 vaccines were driven by mRNA technology solutions from Pfizer-BioNTech and Moderna. They were invented in near-record time, and saved thousands of people from death, illness and hospitalisation from SARS-CoV-2, the virus that caused COVID-19.

Such mRNA vaccines have been part of COVID-19 control and other measures of public health including mask-wearing and social distancing. And have done it also against new strains like Delta, Omicron strains but you never see a new one.

Future Applications of mRNA Vaccines

These mRNA vaccines are for COVID-19, but that’s not the only virus they might be used against, and some are already under consideration by scientists:

Flu: mRNA vaccines are being investigated for the flu season. Since mRNA is so malleable, the vaccine can simply be switched on with the flu virus.

Zika Virus: Research are looking at mRNA vaccines for Zika virus that causes birth defects in babies, when the mother is infected.

HIV: With its ability to adapt to rapidly mutating viruses, mRNA could crack the code for an HIV vaccine.

Cancer Immunotherapy: mRNA technology cancer immunotherapy is the next fad. The mRNA vaccines could be loaded with tumour antigens to turn on the immune system against cancer cells. It’s an experiment yet, but it could turn into a treatment for targeted cancer therapy.

Reminder: Wrapping It Up
mRNA vaccines aren’t just rewriting the rulebook—they’re burning it and starting fresh. Faster to produce, easier to adapt, and boasting fewer risks than traditional methods, these vaccines are shaking up immunology. Sure, there’s still room to grow (distribution and storage need work), but the potential is off the charts.

The mRNA revolution isn’t just here—it’s just getting started. As global medicine leans into this tech, we’re looking at a future where pandemics, once considered unstoppable, are no longer incurable.

Below is a table of the services and products offered by Creative Biolabs, including links to the respective services and products for your convenience.

These offerings highlight the comprehensive range of solutions that Creative Biolabs provides to facilitate vaccine development and research.